Experimental studies suggest that melatonin has a protective effect against
breast cancer. Exposure to light suppresses melatonin secretion, but to a
lesser degree in totally blind persons. Breast cancer was investigated in a
cohort of 15 412 Norwegian visually impaired women. The risk among totally
blind women was 0.64 (95% CI = 0.21-1.49, 5 cases only), and for those who
became blind before age of 65, the SIR was 0.51 (95% CI = 0.11-1.49). Our
findings give support to the 'melatonin hypothesis'. (C) 2001 Cancer Resear
ch Campaign.